Skip to main content
Top
Published in: BMC Oral Health 1/2014

Open Access 01-12-2014 | Research article

Community-level assessment of dental plaque bacteria susceptibility to triclosan over 19 years

Authors: Violet I Haraszthy, Prem K Sreenivasan, Joseph J Zambon

Published in: BMC Oral Health | Issue 1/2014

Login to get access

Abstract

Background

Triclosan is a broad-spectrum antimicrobial agent used in toothpaste to reduce dental plaque, gingivitis and oral malodor. This community-level assessment evaluated the susceptibility of dental plaque bacteria to triclosan in samples collected over 19 years.

Methods

A total of 155 dental plaque samples were collected at eleven different times over 19 years from 58 adults using 0.3% triclosan, 2% copolymer, 0.243% sodium fluoride toothpaste and from 97 adults using toothpaste without triclosan. These included samples from 21 subjects who used triclosan toothpaste for at least five years and samples from 20 control subjects. The samples were cultured on media containing 0, 7.5 or 25 μg/ml triclosan. Descriptive statistics and p values were computed and a linear regression model and the runs test were used to examine susceptibility over time.

Results

Growth inhibition averaged 99.451% (91.209 - 99.830%) on media containing 7.5 μg/ml triclosan and 99.989% (99.670 - 100%) on media containing 25 μg/ml triclosan. There was no change in microbial susceptibility to triclosan over time discernible by regression analysis or the runs test in plaque samples taken over 19 years including samples from subjects using a triclosan-containing dentifrice for at least five years.

Conclusions

This community-level assessment of microbial susceptibility to triclosan among supragingival plaque bacteria is consistent with the long-term safety of a 0.3% triclosan, 2% copolymer, 0.243% sodium fluoride dentifrice.
Literature
1.
go back to reference Furia TE, Schenkel AG: A new, broad spectrum bacteriostat. Soap Chem Spec. 1968, 44: 116-122. Furia TE, Schenkel AG: A new, broad spectrum bacteriostat. Soap Chem Spec. 1968, 44: 116-122.
2.
go back to reference Davies RM, Ellwood RP, Davies GM: The effectiveness of a toothpaste containing triclosan and polyvinyl-methyl ether maleic acid copolymer in improving plaque control and gingival health: a systematic review. J Clin Periodontol. 2004, 31: 1029-1033.CrossRefPubMed Davies RM, Ellwood RP, Davies GM: The effectiveness of a toothpaste containing triclosan and polyvinyl-methyl ether maleic acid copolymer in improving plaque control and gingival health: a systematic review. J Clin Periodontol. 2004, 31: 1029-1033.CrossRefPubMed
3.
go back to reference Sreenivasan PK, Haraszthy VI, Zambon JJ, DeVizio W: Efficacy of a triclosan/copolymer dentifrice and a toothbrush with tongue cleaner in the treatment of oral malodor: A monadic clinical trial. OJST. 2013, 3: 63-69.CrossRef Sreenivasan PK, Haraszthy VI, Zambon JJ, DeVizio W: Efficacy of a triclosan/copolymer dentifrice and a toothbrush with tongue cleaner in the treatment of oral malodor: A monadic clinical trial. OJST. 2013, 3: 63-69.CrossRef
4.
go back to reference Deasy MJ, Singh SM, Rustogi KN, Petrone DM, Battista G, Petrone ME, Volpe AR: Effect of a dentifrice containing triclosan and a copolymer on plaque formation and gingivitis. Clin Prev Dent. 1991, 13: 12-19.PubMed Deasy MJ, Singh SM, Rustogi KN, Petrone DM, Battista G, Petrone ME, Volpe AR: Effect of a dentifrice containing triclosan and a copolymer on plaque formation and gingivitis. Clin Prev Dent. 1991, 13: 12-19.PubMed
5.
go back to reference Niederman R: Triclosan-containing toothpastes reduce plaque and gingivitis. Evid Based Dent. 2005, 6: 33-CrossRefPubMed Niederman R: Triclosan-containing toothpastes reduce plaque and gingivitis. Evid Based Dent. 2005, 6: 33-CrossRefPubMed
6.
go back to reference Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Seymour GJ: The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol. 2003, 30: 414-419.CrossRefPubMed Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Seymour GJ: The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol. 2003, 30: 414-419.CrossRefPubMed
7.
go back to reference Rosling B, Dahlén G, Volpe A, Furuichi Y, Ramberg P, Lindhe J: Effect of triclosan on the subgingival microbiota of periodontitis-susceptible subjects. J Clin Periodontol. 1997, 24: 881-887.CrossRefPubMed Rosling B, Dahlén G, Volpe A, Furuichi Y, Ramberg P, Lindhe J: Effect of triclosan on the subgingival microbiota of periodontitis-susceptible subjects. J Clin Periodontol. 1997, 24: 881-887.CrossRefPubMed
8.
go back to reference Jones CL, Ritchie JA, Marsh PD, Van Der Ouderaa F: The effect of long-term use of a dentifrice containing zinc citrate and a non-ionic agent on the oral flora. J Dent Res. 1988, 67: 46-50.CrossRefPubMed Jones CL, Ritchie JA, Marsh PD, Van Der Ouderaa F: The effect of long-term use of a dentifrice containing zinc citrate and a non-ionic agent on the oral flora. J Dent Res. 1988, 67: 46-50.CrossRefPubMed
9.
go back to reference Zambon JJ, Reynolds HS, Dunford RG, Bonta CY: Effect of a triclosan/copolymer/fluoride dentifrice on the oral microflora. Am J Dent. 1990, 3: S27-S34.PubMed Zambon JJ, Reynolds HS, Dunford RG, Bonta CY: Effect of a triclosan/copolymer/fluoride dentifrice on the oral microflora. Am J Dent. 1990, 3: S27-S34.PubMed
10.
go back to reference Walker C, Borden LC, Zambon JJ, Bonta CY, DeVizio W, Volpe A: The effects of a 0.3% triclosan-containing dentifrice on the microbial composition of dental plaque. J Clin Periodontol. 1994, 21: 334-341.CrossRefPubMed Walker C, Borden LC, Zambon JJ, Bonta CY, DeVizio W, Volpe A: The effects of a 0.3% triclosan-containing dentifrice on the microbial composition of dental plaque. J Clin Periodontol. 1994, 21: 334-341.CrossRefPubMed
11.
go back to reference Zambon JJ, Reynolds HS, Dunford RG, DeVizio W, Volpe AR, Berta R, Tempro JP, Bonta Y: Microbial alterations in supragingival dental plaque in response to a triclosan-containing dentifrice. Oral Microbiol Immunol. 1995, 10: 247-255.CrossRefPubMed Zambon JJ, Reynolds HS, Dunford RG, DeVizio W, Volpe AR, Berta R, Tempro JP, Bonta Y: Microbial alterations in supragingival dental plaque in response to a triclosan-containing dentifrice. Oral Microbiol Immunol. 1995, 10: 247-255.CrossRefPubMed
12.
go back to reference Fine DH, Furgang D, Bontá Y, DeVizio W, Volpe AR, Reynolds H, Zambon JJ, Dunford RG: Efficacy of a triclosan/NaF dentifrice in the control of plaque and gingivitis and concurrent oral microflora monitoring. Am J Dent. 1998, 11: 259-270.PubMed Fine DH, Furgang D, Bontá Y, DeVizio W, Volpe AR, Reynolds H, Zambon JJ, Dunford RG: Efficacy of a triclosan/NaF dentifrice in the control of plaque and gingivitis and concurrent oral microflora monitoring. Am J Dent. 1998, 11: 259-270.PubMed
13.
go back to reference Sullivan A, Wretlind B, Nord CE: Will triclosan in toothpaste select for resistant oral streptococci?. Clin Microbiol Infect. 2003, 9: 306-309.CrossRefPubMed Sullivan A, Wretlind B, Nord CE: Will triclosan in toothpaste select for resistant oral streptococci?. Clin Microbiol Infect. 2003, 9: 306-309.CrossRefPubMed
14.
go back to reference Cullinan MP, Bird PS, Heng NC, West MJ, Seymour GJ: No evidence of triclosan-resistant bacteria following long-term use of triclosan-containing toothpaste. J Periodontal Res. 2013, doi:10.1111/jre.12098 Cullinan MP, Bird PS, Heng NC, West MJ, Seymour GJ: No evidence of triclosan-resistant bacteria following long-term use of triclosan-containing toothpaste. J Periodontal Res. 2013, doi:10.1111/jre.12098
15.
go back to reference Haraszthy VI, Reynolds HS, Sreenivasan PK, Subramanyam R, Cummins D, Zambon JJ: Media- and method-dependent variations in minimal inhibitory concentrations of antiplaque agents on oral bacteria. Lett Appl Microbiol. 2006, 43: 256-261.CrossRefPubMed Haraszthy VI, Reynolds HS, Sreenivasan PK, Subramanyam R, Cummins D, Zambon JJ: Media- and method-dependent variations in minimal inhibitory concentrations of antiplaque agents on oral bacteria. Lett Appl Microbiol. 2006, 43: 256-261.CrossRefPubMed
16.
go back to reference Sreenivasan PK, Vered Y, Zini A, Mann J, Kolog H, Steinberg D, Zambon JJ, Haraszthy VI, da Silva MP, DeVizio W: A six-month study of the effects of 0.3% triclosan/copolymer dentifrice on dental implants. J Clin Periodontol. 2011, 38: 33-42.CrossRefPubMed Sreenivasan PK, Vered Y, Zini A, Mann J, Kolog H, Steinberg D, Zambon JJ, Haraszthy VI, da Silva MP, DeVizio W: A six-month study of the effects of 0.3% triclosan/copolymer dentifrice on dental implants. J Clin Periodontol. 2011, 38: 33-42.CrossRefPubMed
17.
go back to reference Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, Beck J, Douglass G, Page R: Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012, 91: 914-920.CrossRefPubMed Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, Beck J, Douglass G, Page R: Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012, 91: 914-920.CrossRefPubMed
18.
go back to reference Dasanayake AP, Chhun N, Tanner AC, Craig RG, Lee MJ, Moore AF, Norman RG: Periodontal pathogens and gestational diabetes mellitus. J Dent Res. 2008, 87: 328-333.CrossRefPubMedPubMedCentral Dasanayake AP, Chhun N, Tanner AC, Craig RG, Lee MJ, Moore AF, Norman RG: Periodontal pathogens and gestational diabetes mellitus. J Dent Res. 2008, 87: 328-333.CrossRefPubMedPubMedCentral
19.
go back to reference Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S: Periodontal disease and cardiovascular disease. J Periodontol. 1996, 67 (Suppl 10): 1123-1137.CrossRefPubMed Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S: Periodontal disease and cardiovascular disease. J Periodontol. 1996, 67 (Suppl 10): 1123-1137.CrossRefPubMed
20.
go back to reference Mealey BL, Oates TW: Diabetes mellitus and periodontal diseases. J Periodontol. 2006, 77: 1289-1303.CrossRefPubMed Mealey BL, Oates TW: Diabetes mellitus and periodontal diseases. J Periodontol. 2006, 77: 1289-1303.CrossRefPubMed
22.
go back to reference Heath RI, Rock CA: Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem. 1995, 270: 26538-26542.CrossRefPubMed Heath RI, Rock CA: Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem. 1995, 270: 26538-26542.CrossRefPubMed
23.
go back to reference Heath RI, Li J, Roland GE, Rock CA: Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem. 2000, 275: 4654-4659.CrossRefPubMed Heath RI, Li J, Roland GE, Rock CA: Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem. 2000, 275: 4654-4659.CrossRefPubMed
24.
go back to reference Heath RI, Su N, Murphy CK, Rock CA: The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis. J Biol Chem. 2000, 275: 40128-40133.CrossRefPubMed Heath RI, Su N, Murphy CK, Rock CA: The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis. J Biol Chem. 2000, 275: 40128-40133.CrossRefPubMed
25.
26.
go back to reference Villalaín J, Mateo CR, Aranda FJ, Shapiro S, Micol V: Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys. 2001, 390: 128-136.CrossRefPubMed Villalaín J, Mateo CR, Aranda FJ, Shapiro S, Micol V: Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys. 2001, 390: 128-136.CrossRefPubMed
27.
go back to reference Phan TN, Marquis RE: Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. Can J Microbiol. 2006, 52: 977-983.CrossRefPubMed Phan TN, Marquis RE: Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. Can J Microbiol. 2006, 52: 977-983.CrossRefPubMed
28.
go back to reference Cekici A, Kantarci A, Hasturk H, Van Dyke TE: Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014, 64: 57-80.CrossRefPubMedPubMedCentral Cekici A, Kantarci A, Hasturk H, Van Dyke TE: Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014, 64: 57-80.CrossRefPubMedPubMedCentral
29.
go back to reference Barros SP, Wirojchanasak S, Barrow DA, Panagakos FS, DeVizio W, Offenbacher S: Triclosan inhibition of acute and chronic inflammatory gene pathways. J Clin Periodontol. 2010, 37: 412-418.CrossRefPubMed Barros SP, Wirojchanasak S, Barrow DA, Panagakos FS, DeVizio W, Offenbacher S: Triclosan inhibition of acute and chronic inflammatory gene pathways. J Clin Periodontol. 2010, 37: 412-418.CrossRefPubMed
30.
go back to reference Wallet MA, Calderon N, Alonso TR, Choe CS, Catalfamo D, Lalane CJ, Neiva KG, Panagakos F, Wallet SM: Triclosan alters antimicrobial and inflammatory responses of epithelial cells. Oral Dis. 2013, 19: 296-302.PubMedPubMedCentral Wallet MA, Calderon N, Alonso TR, Choe CS, Catalfamo D, Lalane CJ, Neiva KG, Panagakos F, Wallet SM: Triclosan alters antimicrobial and inflammatory responses of epithelial cells. Oral Dis. 2013, 19: 296-302.PubMedPubMedCentral
31.
go back to reference Mustafa M, Wondimu B, Yucel-Lindberg T, Kats-Hallström AT, Jonsson AS, Modéer T: Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. J Clin Periodontol. 2005, 32: 6-11.CrossRefPubMed Mustafa M, Wondimu B, Yucel-Lindberg T, Kats-Hallström AT, Jonsson AS, Modéer T: Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. J Clin Periodontol. 2005, 32: 6-11.CrossRefPubMed
32.
go back to reference Yazdankhah SP, Scheie AA, Høiby EA, Lunestad BT, Heir E, Fotland TØ, Naterstad K, Kruse H: Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist. 2006, 12: 83-90.CrossRefPubMed Yazdankhah SP, Scheie AA, Høiby EA, Lunestad BT, Heir E, Fotland TØ, Naterstad K, Kruse H: Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist. 2006, 12: 83-90.CrossRefPubMed
33.
go back to reference Zgurskaya HI, Nikaido H: Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol. 2000, 37: 219-225.CrossRefPubMed Zgurskaya HI, Nikaido H: Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol. 2000, 37: 219-225.CrossRefPubMed
34.
go back to reference Webber MA, Randall LP, Cooles S, Woodward MJ, Piddock LJ: Triclosan resistance in Salmonella enterica serovar typhimurium. J Antimicrob Chemother. 2008, 62: 83-91.CrossRefPubMed Webber MA, Randall LP, Cooles S, Woodward MJ, Piddock LJ: Triclosan resistance in Salmonella enterica serovar typhimurium. J Antimicrob Chemother. 2008, 62: 83-91.CrossRefPubMed
Metadata
Title
Community-level assessment of dental plaque bacteria susceptibility to triclosan over 19 years
Authors
Violet I Haraszthy
Prem K Sreenivasan
Joseph J Zambon
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2014
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/1472-6831-14-61

Other articles of this Issue 1/2014

BMC Oral Health 1/2014 Go to the issue